• About
    • About the Alliance
    • APC News
    • What is Pharmacy Compounding?
    • What We Stand For
    • Leadership
    • Professional Staff
    • Pharmacy Compounding Foundation
    • APC Fellows Program
    • 2024 Compounding Snapshot
    • Contact APC
  • Advocacy
    • APC Statements
    • Federal Issue Priorities
    • State-Level Resources
    • CompPAC: Cultivating Champions
    • OneFund: Support APC Advocacy
  • Education
    • Compounding Law and Patient Safety
    • 15-Hour Compounding Course
    • Continuing Education
    • EduCon
    • Prescriber Briefs
  • Events
    • APC Calendar
    • EduCon 2024
    • Compounders on Capitol Hill 2024
    • Owner Summit 2025
  • Practice
    • Compounder Resources
    • Ethical Compounding
    • Patient Reported Outcomes
    • Save cBHT
    • Save cBHT: Campaign Tools
  • Vendors
    • Corporate Patrons
    • Sponsor/Exhibit Opportunities
  • Member Portal
    • Login
    • Individual Profile
    • Company Profile
    • Pay Bills
    • Invest!
    • Career Center
  • Join/Renew
 

Big buttons

Find

Careers

Press Room

News

  • Poll: Consumers like you, they really like you (well, those who know about you)
    A new national poll gives some telling information about consumers' views on compounding
  • Semaglutide shortage resolved
    Here's what we know so far
  • Our tirzepatide memo to BoPs
    We wrote a simple, 2-page memo for state boards explaining the current legal and regulatory situation around compounding tirzepatide. 
  • State advocacy updates: Feb. 28, 2025
    News from Nebraska, Iowa, and Florida
  • About that Super Bowl ad…
    The media has been turning to APC for perspective on the Hims & Hers Super Bowl ad ... a lot.
  • Once more with monotone: FDA again clarifies discretion on tirzepatide copies
    The FDA again clarified its enforcement discretion policy for compounded copies of tirzepatide injections.
  • State advocacy update: California (again)
    In yet another letter to the California Board of Pharmacy, we had to express our serious concerns about proposed compounding regulations.
  • Another loss for Novo
    A federal judge has ruled against Novo Nordisk in a case the company made against a compounding pharmacy.
  • State advocacy updates: Feb. 14, 2025
    Updates on Washington and Louisiana
  • Good news in the court
    A federal court dismissed Novo Nordisk’s lawsuit against Live Well Drugstore — this is good news for a few reasons.

More news


» More APC News «


 
 

From APC: ‘Your unrelenting desire to do right by your patients’ and more | 15 Dec 2023


 

CONTACT US

E-mail: info@a4pc.org
Phone: (281) 933-8400
Fax: (281) 495-0602
Mailing: Alliance for Pharmacy Compounding
100 Daingerfield Road, Ste. 100
Alexandria, VA 22314

APC is committed to addressing any concerns or complaints within one business day. Please send them — and, of course, any compliments — to info@a4pc.org.

APC GOVERNANCE

APC Board of Directors

APC Corporate Patrons

APC Governing Policies (PDF)

APC Bylaws (PDF)

APC Professional Staff

THE APC FAMILY

Pharmacy Compounding Foundation

CompPAC

OneFund

Career Center

P3 (our grassroots network)

Compounding.com

FOLLOW US

LinkedIn Facebook RSS Feed

© Alliance for Pharmacy Compounding. All rights reserved.